EFRI DCheM: Distributed Ribonucleic Acid (RNA) Manufacturing via Continuous Enzymatic Reac — NSF Award to University of Pennsylvan
Vaccines based on messenger RNA (mRNA) have played a crucial role in changing the trajectory of the COVID-19 pandemic and will become increasingly important in developing new vaccines for future diseases. RNA-based therapies are also projected to have a major impact in formulating new cancer treatments as well as regen
| Award title | EFRI DCheM: Distributed Ribonucleic Acid (RNA) Manufacturing via Continuous Enzymatic Reac |
|---|---|
| Award ID | 2132141 |
| Awardee | University of Pennsylvania |
| City | PHILADELPHIA |
| State | PA |
| Amount obligated | $1,999,998 |
| Principal investigator | Daeyeon Lee |
| Program | EFRI Research Projects |
| Start date | 09/01/2021 |
| Abstract | Vaccines based on messenger RNA (mRNA) have played a crucial role in changing the trajectory of the COVID-19 pandemic and will become increasingly important in developing new vaccines for future diseases. RNA-based therapies are also projected to have a major impact in formulating new cancer treatments as well as regenerative medicines that enable repair and regrowth of damaged tissues. Despite their proven effectiveness and enormous potential, RNA-based therapies are notoriously difficult to di |
| Source | NSF Awards |
$799/mo
Try NSFGrants →